- £151.62m
- £263.22m
- £349.70m
- 51
- 65
- 86
- 80
2019 March 30th | 2020 March 28th | 2021 March 27th | 2022 March 26th | 2023 March 25th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 565 | 467 | 397 | 375 | 350 |
Cost of Revenue | |||||
Gross Profit | — | 106 | 108 | 97.6 | 92.1 |
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 533 | 424 | 383 | 345 | 371 |
Operating Profit | 31.5 | 42.8 | 14.5 | 29.7 | -21.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.5 | 36.1 | 9.9 | 24.2 | -29.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 20.7 | 36.1 | 8.6 | 22.9 | -57.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 17 | 34.1 | 6 | 21.5 | -55.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17 | 34.1 | 5.9 | 21.5 | -55.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.456 | 0.166 | 0.258 | 0.142 | -0.067 |
Dividends per Share |